GLP-1 Drugs: Universal Weight Loss
8:57–10:09 · 71s
Eli Lilly CEO David Ricks highlights how products like Zepbound deliver weight loss for almost every patient, positioning them as potentially more transformative than AI.
8:57–10:09 · 71s
Eli Lilly CEO David Ricks highlights how products like Zepbound deliver weight loss for almost every patient, positioning them as potentially more transformative than AI.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.